[Drug therapy of hemodynamic complications in acute myocardial infarct].
D000368:Aged; D000698:Analgesia; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001810:Blood Volume; D001919:Bradycardia / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology; D003975:Diazepam / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000188:drug therapy; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D009638:Norepinephrine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D004232:Diuretics; D010952:Plasma Substitutes; D004077:Digoxin; D005934:Glucagon; D003975:Diazepam; D011188:Potassium; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine
Medikamentöse Behandlung hämodynamischer Komplikationen bei akutem Myokardinfarkt.